RARX

Ra Pharmaceuticals, Inc.CIK 1481512 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for RARX PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for RARX

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Ricardo Alonso	See Remarks	15	$0	$554.5K	2020-04-02
King John C	Chief Commercial Officer	10	$0	$0	2020-04-02
Brennan Aoife	Director	4	$0	$0	2020-04-02
Heft Robert	Director	7	$0	$0	2020-04-02
Read Simon	Chief Scientific Officer	37	$0	$2.49M	2020-04-02
Farzaneh-Far Ramin	Chief Medical Officer	66	$0	$4.11M	2020-04-02
Treco Douglas A	President and CEO	15	$0	$0	2020-04-02
Cumbo Alexander	Director	4	$0	$0	2020-04-02
Shah Rajeev M.	Director, 10% Owner	14	$32.70M	$0	2020-04-02
Lubner David Charles	Executive VP and CFO	16	$0	$0	2020-04-02
PEARSON TIMOTHY R	Director	7	$0	$0	2020-04-02
NEA 13 GP, Ltd	10% Owner	12	$16.40M	$5.7K	2020-04-02
Mathers Edward T	Director	6	$0	$0	2020-04-02
RA Capital Healthcare Fund LP	Director, 10% Owner	7	$2.10M	$0	2020-04-02
NEA Partners 13, Limited Partnership	10% Owner	1	$10.00M	$0	2018-12-14
RA CAPITAL MANAGEMENT, LLC	Director, 10% Owner	1	$15.60M	$0	2018-12-12
Bisgaard Peter	Director	2	$0	$0	2018-06-28
Kolchinsky Peter	Director, 10% Owner	4	$15.00M	$0	2018-06-28
Lettmann Jason	Director, 10% Owner	21	$5.12M	$4.4K	2017-06-20
NOVARTIS AG	10% Owner	28	$1.10M	$6.05M	2017-06-19
Novartis Bioventures Ltd	10% Owner	3	$0	$689.4K	2017-06-05
Viswanathan Ravi	10% Owner	10	$4.40M	$5.7K	2016-10-31
MORGENTHALER VENTURE PARTNERS IX LP	10% Owner	10	$3.43M	$4.4K	2016-10-31
Novo A/S	10% Owner	5	$3.20M	$0	2016-10-31
Weller Harry R	10% Owner	10	$4.40M	$5.7K	2016-10-31
BASKETT FOREST	10% Owner	10	$4.40M	$5.7K	2016-10-31
KOLLURI KRISHNA KITTU	10% Owner	10	$4.40M	$5.7K	2016-10-31
SANDELL SCOTT D	10% Owner	10	$4.40M	$5.7K	2016-10-31
KERINS PATRICK J	10% Owner	10	$4.40M	$5.7K	2016-10-31
MOTT DAVID M	10% Owner	10	$4.40M	$5.7K	2016-10-31
BARRETT M JAMES	10% Owner	10	$4.40M	$5.7K	2016-10-31
BARRIS PETER J	10% Owner	10	$4.40M	$5.7K	2016-10-31

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Brennan Aoife	Director	D To issuer deriv	2020-04-02	2020-04-03	25,000	—	$0	0	SEC↗
Brennan Aoife	Director	D To issuer deriv	2020-04-02	2020-04-03	15,000	—	$0	0	SEC↗
Heft Robert	Director	D To issuer deriv	2020-04-02	2020-04-03	22,857	—	$0	0	SEC↗
Heft Robert	Director	D To issuer deriv	2020-04-02	2020-04-03	15,000	—	$0	0	SEC↗
Heft Robert	Director	D To issuer deriv	2020-04-02	2020-04-03	15,000	—	$0	0	SEC↗
Heft Robert	Director	D To issuer deriv	2020-04-02	2020-04-03	15,000	—	$0	0	SEC↗
Shah Rajeev M.	Director, 10% Owner	D To issuer deriv	2020-04-02	2020-04-03	15,000	—	$0	0	SEC↗
Shah Rajeev M.	Director, 10% Owner	D To issuer deriv	2020-04-02	2020-04-03	15,000	—	$0	0	SEC↗
Shah Rajeev M.	Director, 10% Owner	D To issuer deriv	2020-04-02	2020-04-03	15,000	—	$0	0	SEC↗
King John C	Chief Commercial Officer	D To issuer deriv	2020-04-02	2020-04-03	30,658	—	$0	0	SEC↗
King John C	Chief Commercial Officer	D To issuer deriv	2020-04-02	2020-04-03	107,000	—	$0	0	SEC↗
King John C	Chief Commercial Officer	D To issuer deriv	2020-04-02	2020-04-03	190,000	—	$0	0	SEC↗
PEARSON TIMOTHY R	Director	D To issuer deriv	2020-04-02	2020-04-03	15,000	—	$0	0	SEC↗
PEARSON TIMOTHY R	Director	D To issuer deriv	2020-04-02	2020-04-03	15,000	—	$0	0	SEC↗
PEARSON TIMOTHY R	Director	D To issuer deriv	2020-04-02	2020-04-03	22,857	—	$0	0	SEC↗
PEARSON TIMOTHY R	Director	D To issuer deriv	2020-04-02	2020-04-03	15,000	—	$0	0	SEC↗
Cumbo Alexander	Director	D To issuer deriv	2020-04-02	2020-04-03	25,000	—	$0	0	SEC↗
Cumbo Alexander	Director	D To issuer deriv	2020-04-02	2020-04-03	15,000	—	$0	0	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	D To issuer deriv	2020-04-02	2020-04-03	73,654	—	$0	0	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	D To issuer deriv	2020-04-02	2020-04-03	11,110	—	$0	0	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	D To issuer deriv	2020-04-02	2020-04-03	90,000	—	$0	0	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	D To issuer deriv	2020-04-02	2020-04-03	62,500	—	$0	0	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	D To issuer deriv	2020-04-02	2020-04-03	133,000	—	$0	0	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	D To issuer deriv	2020-04-02	2020-04-03	10,416	—	$0	0	SEC↗
Read Simon	Chief Scientific Officer	D To issuer deriv	2020-04-02	2020-04-03	107,000	—	$0	0	SEC↗
Read Simon	Chief Scientific Officer	D To issuer deriv	2020-04-02	2020-04-03	9,166	—	$0	0	SEC↗
Read Simon	Chief Scientific Officer	D To issuer deriv	2020-04-02	2020-04-03	55,000	—	$0	0	SEC↗
Read Simon	Chief Scientific Officer	D To issuer deriv	2020-04-02	2020-04-03	46,434	—	$0	0	SEC↗
Read Simon	Chief Scientific Officer	D To issuer deriv	2020-04-02	2020-04-03	26,422	—	$0	0	SEC↗
Read Simon	Chief Scientific Officer	D To issuer deriv	2020-04-02	2020-04-03	25,000	—	$0	0	SEC↗
Read Simon	Chief Scientific Officer	D To issuer deriv	2020-04-02	2020-04-03	67,500	—	$0	0	SEC↗
Ricardo Alonso	See Remarks	D To issuer deriv	2020-04-02	2020-04-03	31,428	—	$0	0	SEC↗
Ricardo Alonso	See Remarks	D To issuer deriv	2020-04-02	2020-04-03	60,000	—	$0	0	SEC↗
Ricardo Alonso	See Remarks	D To issuer deriv	2020-04-02	2020-04-03	26,250	—	$0	0	SEC↗
Ricardo Alonso	See Remarks	D To issuer deriv	2020-04-02	2020-04-03	107,000	—	$0	0	SEC↗
Ricardo Alonso	See Remarks	D To issuer deriv	2020-04-02	2020-04-03	4,375	—	$0	0	SEC↗
Ricardo Alonso	See Remarks	D To issuer deriv	2020-04-02	2020-04-03	30,000	—	$0	0	SEC↗
Ricardo Alonso	See Remarks	D To issuer deriv	2020-04-02	2020-04-03	14,285	—	$0	0	SEC↗
Ricardo Alonso	See Remarks	D To issuer deriv	2020-04-02	2020-04-03	2,857	—	$0	0	SEC↗
Lubner David Charles	Executive VP and CFO	D To issuer deriv	2020-04-02	2020-04-03	115,572	—	$0	0	SEC↗
Lubner David Charles	Executive VP and CFO	D To issuer deriv	2020-04-02	2020-04-03	92,283	—	$0	0	SEC↗
Lubner David Charles	Executive VP and CFO	D To issuer deriv	2020-04-02	2020-04-03	28,571	—	$0	0	SEC↗
Lubner David Charles	Executive VP and CFO	D To issuer deriv	2020-04-02	2020-04-03	112,500	—	$0	0	SEC↗
Lubner David Charles	Executive VP and CFO	D To issuer deriv	2020-04-02	2020-04-03	62,500	—	$0	0	SEC↗
Lubner David Charles	Executive VP and CFO	D To issuer deriv	2020-04-02	2020-04-03	10,416	—	$0	0	SEC↗
Lubner David Charles	Executive VP and CFO	D To issuer deriv	2020-04-02	2020-04-03	133,000	—	$0	0	SEC↗
Treco Douglas A	President and CEO	D To issuer deriv	2020-04-02	2020-04-03	125,000	—	$0	0	SEC↗
Treco Douglas A	President and CEO	D To issuer deriv	2020-04-02	2020-04-03	139,371	—	$0	0	SEC↗
Treco Douglas A	President and CEO	D To issuer deriv	2020-04-02	2020-04-03	241,460	—	$0	0	SEC↗
Treco Douglas A	President and CEO	D To issuer deriv	2020-04-02	2020-04-03	164,285	—	$0	0	SEC↗
Treco Douglas A	President and CEO	D To issuer deriv	2020-04-02	2020-04-03	20,833	—	$0	0	SEC↗
Treco Douglas A	President and CEO	D To issuer deriv	2020-04-02	2020-04-03	311,000	—	$0	0	SEC↗
Treco Douglas A	President and CEO	D To issuer deriv	2020-04-02	2020-04-03	225,000	—	$0	0	SEC↗
Mathers Edward T	Director	D To issuer deriv	2020-04-02	2020-04-03	15,000	—	$0	0	SEC↗
Mathers Edward T	Director	D To issuer deriv	2020-04-02	2020-04-03	15,000	—	$0	0	SEC↗
Mathers Edward T	Director	D To issuer deriv	2020-04-02	2020-04-03	15,000	—	$0	0	SEC↗
RA Capital Healthcare Fund LP	Director, 10% Owner	D To issuer	2020-04-02	2020-04-03	4,858,260	$48.00	$233.20M	0	SEC↗
Shah Rajeev M.	Director, 10% Owner	D To issuer	2020-04-02	2020-04-03	4,858,260	$48.00	$233.20M	0	SEC↗
King John C	Chief Commercial Officer	D To issuer	2020-04-02	2020-04-03	10,823	$48.00	$519.5K	0	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	D To issuer	2020-04-02	2020-04-03	14,492	$48.00	$695.6K	0	SEC↗
Read Simon	Chief Scientific Officer	D To issuer	2020-04-02	2020-04-03	12,595	$48.00	$604.6K	0	SEC↗
Ricardo Alonso	See Remarks	D To issuer	2020-04-02	2020-04-03	2,973	$48.00	$142.7K	0	SEC↗
Lubner David Charles	Executive VP and CFO	D To issuer	2020-04-02	2020-04-03	15,622	$48.00	$749.9K	0	SEC↗
Treco Douglas A	President and CEO	D To issuer	2020-04-02	2020-04-03	234,707	$48.00	$11.27M	0	SEC↗
NEA 13 GP, Ltd	10% Owner	D To issuer	2020-04-02	2020-04-03	6,135,234	—	$0	0	SEC↗
Ricardo Alonso	See Remarks	S Sale	2020-03-17	2020-03-18	2,288	$44.25	$101.2K	0	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise deriv	2020-03-16	2020-03-18	9,206	—	$0	73,654	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise deriv	2020-03-16	2020-03-18	1,389	—	$0	11,110	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	S Sale	2020-03-16	2020-03-18	10,595	$45.16	$478.5K	7,132	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise	2020-03-16	2020-03-18	1,389	$5.60	$7.8K	8,521	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise	2020-03-16	2020-03-18	9,206	$5.60	$51.6K	17,727	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise deriv	2020-02-18	2020-02-20	1,389	—	$0	12,499	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise deriv	2020-02-18	2020-02-20	9,206	—	$0	82,860	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	S Sale	2020-02-18	2020-02-20	10,595	$46.61	$493.8K	7,132	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise	2020-02-18	2020-02-20	9,206	$5.60	$51.6K	17,727	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise	2020-02-18	2020-02-20	1,389	$5.60	$7.8K	8,521	SEC↗
Ricardo Alonso	See Remarks	S Sale	2020-01-17	2020-01-21	2,285	$47.02	$107.4K	2,288	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise deriv	2020-01-15	2020-01-16	9,206	—	$0	92,066	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise deriv	2020-01-15	2020-01-16	1,389	—	$0	13,888	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise	2020-01-15	2020-01-16	9,206	$5.60	$51.6K	17,727	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise	2020-01-15	2020-01-16	1,389	$5.60	$7.8K	8,521	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	S Sale	2020-01-15	2020-01-16	10,595	$46.95	$497.4K	7,132	SEC↗
Read Simon	Chief Scientific Officer	M Exercise deriv	2019-12-17	2019-12-18	10,000	—	$0	46,142	SEC↗
Read Simon	Chief Scientific Officer	S Sale	2019-12-17	2019-12-18	10,000	$47.08	$470.8K	6,234	SEC↗
Read Simon	Chief Scientific Officer	M Exercise	2019-12-17	2019-12-18	10,000	$2.87	$28.7K	16,234	SEC↗
Ricardo Alonso	See Remarks	S Sale	2019-12-17	2019-12-18	2,285	$47.08	$107.6K	4,573	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise deriv	2019-12-16	2019-12-18	1,389	—	$0	15,277	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise deriv	2019-12-16	2019-12-18	9,206	—	$0	101,272	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise	2019-12-16	2019-12-18	9,206	$5.60	$51.6K	17,727	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise	2019-12-16	2019-12-18	1,389	$5.60	$7.8K	8,521	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	S Sale	2019-12-16	2019-12-18	10,595	$47.23	$500.4K	7,132	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise deriv	2019-11-15	2019-11-18	9,206	—	$0	110,478	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise deriv	2019-11-15	2019-11-18	1,389	—	$0	16,666	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	S Sale	2019-11-15	2019-11-18	10,595	$46.66	$494.4K	7,132	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise	2019-11-15	2019-11-18	9,206	$5.60	$51.6K	17,727	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise	2019-11-15	2019-11-18	1,389	$5.60	$7.8K	8,521	SEC↗
Read Simon	Chief Scientific Officer	M Exercise deriv	2019-11-14	2019-11-18	10,000	—	$0	56,142	SEC↗
Read Simon	Chief Scientific Officer	S Sale	2019-11-14	2019-11-18	10,000	$46.68	$466.8K	6,234	SEC↗
Read Simon	Chief Scientific Officer	M Exercise	2019-11-14	2019-11-18	10,000	$2.87	$28.7K	16,234	SEC↗
Ricardo Alonso	See Remarks	S Sale	2019-10-17	2019-10-17	2,285	$46.70	$106.7K	6,858	SEC↗
Read Simon	Chief Scientific Officer	M Exercise deriv	2019-10-16	2019-10-17	10,000	—	$0	66,142	SEC↗
Read Simon	Chief Scientific Officer	M Exercise	2019-10-16	2019-10-17	10,000	$2.87	$28.7K	16,234	SEC↗
Read Simon	Chief Scientific Officer	S Sale	2019-10-16	2019-10-17	10,000	$46.87	$468.7K	6,234	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise deriv	2019-10-15	2019-10-17	1,389	—	$0	18,055	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise deriv	2019-10-15	2019-10-17	9,206	—	$0	119,684	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise	2019-10-15	2019-10-17	9,206	$5.60	$51.6K	17,727	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise	2019-10-15	2019-10-17	1,389	$5.60	$7.8K	8,521	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	S Sale	2019-10-15	2019-10-17	10,595	$46.89	$496.8K	7,132	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise deriv	2019-09-16	2019-09-16	9,206	—	$0	128,890	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise deriv	2019-09-16	2019-09-16	1,389	—	$0	19,444	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise	2019-09-16	2019-09-16	1,389	$5.60	$7.8K	8,521	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise	2019-09-16	2019-09-16	9,206	$5.60	$51.6K	17,727	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	S Sale	2019-09-16	2019-09-16	10,595	$25.26	$267.6K	7,132	SEC↗
Read Simon	Chief Scientific Officer	M Exercise deriv	2019-09-12	2019-09-16	10,000	—	$0	76,142	SEC↗
Read Simon	Chief Scientific Officer	M Exercise	2019-09-12	2019-09-16	10,000	$2.87	$28.7K	16,234	SEC↗
Read Simon	Chief Scientific Officer	S Sale	2019-09-12	2019-09-16	10,000	$25.41	$254.1K	6,234	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise deriv	2019-08-23	2019-08-27	1,389	—	$0	20,833	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise deriv	2019-08-23	2019-08-27	9,206	—	$0	138,096	SEC↗
Read Simon	Chief Scientific Officer	M Exercise deriv	2019-08-23	2019-08-27	10,000	—	$0	86,142	SEC↗
Ricardo Alonso	See Remarks	S Sale	2019-08-23	2019-08-27	2,285	$27.89	$63.7K	9,143	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise	2019-08-23	2019-08-27	1,389	$5.60	$7.8K	8,521	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise	2019-08-23	2019-08-27	9,206	$5.60	$51.6K	17,727	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	S Sale	2019-08-23	2019-08-27	10,595	$27.77	$294.2K	7,132	SEC↗
Read Simon	Chief Scientific Officer	M Exercise	2019-08-23	2019-08-27	10,000	$2.87	$28.7K	16,234	SEC↗
Read Simon	Chief Scientific Officer	S Sale	2019-08-23	2019-08-27	10,000	$27.77	$277.7K	6,234	SEC↗
Read Simon	Chief Scientific Officer	M Exercise deriv	2019-07-17	2019-07-18	10,000	—	$0	96,142	SEC↗
Read Simon	Chief Scientific Officer	M Exercise	2019-07-17	2019-07-18	10,000	$2.87	$28.7K	16,234	SEC↗
Read Simon	Chief Scientific Officer	S Sale	2019-07-17	2019-07-18	10,000	$32.95	$329.5K	6,234	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise deriv	2019-07-15	2019-07-16	1,389	—	$0	22,222	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise deriv	2019-07-15	2019-07-16	9,206	—	$0	147,302	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise	2019-07-15	2019-07-16	9,206	$5.60	$51.6K	17,727	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	S Sale	2019-07-15	2019-07-16	6,379	$32.97	$210.3K	11,348	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	S Sale	2019-07-15	2019-07-16	4,216	$33.29	$140.4K	7,132	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise	2019-07-15	2019-07-16	1,389	$5.60	$7.8K	8,521	SEC↗
Ricardo Alonso	See Remarks	S Sale	2019-06-21	2019-06-25	2,857	$23.72	$67.8K	11,428	SEC↗
Read Simon	Chief Scientific Officer	M Exercise deriv	2019-06-18	2019-06-19	10,000	—	$0	106,142	SEC↗
Read Simon	Chief Scientific Officer	M Exercise	2019-06-18	2019-06-19	10,000	$2.87	$28.7K	16,234	SEC↗
Read Simon	Chief Scientific Officer	S Sale	2019-06-18	2019-06-19	414	$23.09	$9.6K	6,234	SEC↗
Read Simon	Chief Scientific Officer	S Sale	2019-06-18	2019-06-19	9,586	$22.21	$212.9K	6,648	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise deriv	2019-06-17	2019-06-19	9,206	—	$0	156,508	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise deriv	2019-06-17	2019-06-19	1,389	—	$0	23,611	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise	2019-06-17	2019-06-19	9,206	$5.60	$51.6K	17,727	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	S Sale	2019-06-17	2019-06-19	3,411	$21.41	$73.0K	14,316	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	S Sale	2019-06-17	2019-06-19	7,184	$22.04	$158.3K	7,132	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise	2019-06-17	2019-06-19	1,389	$5.60	$7.8K	8,521	SEC↗
Mathers Edward T	Director	A Award deriv	2019-06-11	2019-06-13	15,000	—	$0	15,000	SEC↗
RA Capital Healthcare Fund LP	10% Owner	A Award deriv	2019-06-11	2019-06-13	15,000	—	$0	15,000	SEC↗
Heft Robert	Director	A Award deriv	2019-06-11	2019-06-13	15,000	—	$0	15,000	SEC↗
Brennan Aoife	Director	A Award deriv	2019-06-11	2019-06-13	15,000	—	$0	15,000	SEC↗
PEARSON TIMOTHY R	Director	A Award deriv	2019-06-11	2019-06-13	15,000	—	$0	15,000	SEC↗
Cumbo Alexander	Director	A Award deriv	2019-06-11	2019-06-13	15,000	—	$0	15,000	SEC↗
Shah Rajeev M.	Director, 10% Owner	A Award deriv	2019-06-11	2019-06-13	15,000	—	$0	15,000	SEC↗
King John C	Chief Commercial Officer	M Exercise deriv	2019-04-16	2019-04-18	15,329	—	$0	30,658	SEC↗
King John C	Chief Commercial Officer	F Tax w/h	2019-04-16	2019-04-18	4,506	$21.93	$98.8K	10,823	SEC↗
King John C	Chief Commercial Officer	M Exercise	2019-04-16	2019-04-18	15,329	—	$0	15,329	SEC↗
Treco Douglas A	President and CEO	A Award deriv	2019-02-01	2019-02-05	311,000	—	$0	311,000	SEC↗
Treco Douglas A	President and CEO	M Exercise deriv	2019-02-01	2019-02-05	20,834	—	$0	41,666	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	A Award deriv	2019-02-01	2019-02-05	133,000	—	$0	133,000	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise deriv	2019-02-01	2019-02-05	10,417	—	$0	20,833	SEC↗
Read Simon	Chief Scientific Officer	M Exercise deriv	2019-02-01	2019-02-05	9,167	—	$0	18,333	SEC↗
Read Simon	Chief Scientific Officer	A Award deriv	2019-02-01	2019-02-05	107,000	—	$0	107,000	SEC↗
Lubner David Charles	Executive V.P. & CFO	M Exercise deriv	2019-02-01	2019-02-05	10,417	—	$0	20,833	SEC↗
Lubner David Charles	Executive V.P. & CFO	A Award deriv	2019-02-01	2019-02-05	133,000	—	$0	133,000	SEC↗
King John C	Chief Commercial Officer	A Award deriv	2019-02-01	2019-02-05	107,000	—	$0	107,000	SEC↗
Treco Douglas A	President and CEO	F Tax w/h	2019-02-01	2019-02-05	6,327	$21.00	$132.9K	218,799	SEC↗
Treco Douglas A	President and CEO	M Exercise	2019-02-01	2019-02-05	20,834	—	$0	225,126	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	F Tax w/h	2019-02-01	2019-02-05	3,285	$21.00	$69.0K	7,132	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	M Exercise	2019-02-01	2019-02-05	10,417	—	$0	10,417	SEC↗
Read Simon	Chief Scientific Officer	F Tax w/h	2019-02-01	2019-02-05	2,933	$21.00	$61.6K	6,234	SEC↗
Read Simon	Chief Scientific Officer	M Exercise	2019-02-01	2019-02-05	9,167	—	$0	9,167	SEC↗
Lubner David Charles	Executive V.P. & CFO	F Tax w/h	2019-02-01	2019-02-05	3,291	$21.00	$69.1K	7,126	SEC↗
Lubner David Charles	Executive V.P. & CFO	M Exercise	2019-02-01	2019-02-05	10,417	—	$0	10,417	SEC↗
Shah Rajeev M.	Director, 10% Owner	P Buy	2018-12-14	2018-12-14	1,006,452	$15.50	$15.60M	4,858,260	SEC↗
NEA Partners 13, Limited Partn	10% Owner	P Buy	2018-12-14	2018-12-14	645,161	$15.50	$10.00M	6,135,234	SEC↗
RA CAPITAL MANAGEMENT, LLC	Director, 10% Owner	P Buy	2018-12-12	2018-12-14	1,006,452	$15.50	$15.60M	4,858,260	SEC↗
Cumbo Alexander	Director	A Award deriv	2018-11-14	2018-11-15	25,000	—	$0	25,000	SEC↗
Brennan Aoife	Director	A Award deriv	2018-09-21	2018-09-25	25,000	—	$0	25,000	SEC↗
Kolchinsky Peter	Director, 10% Owner	A Award deriv	2018-06-28	2018-11-01	15,000	—	$0	15,000	SEC↗
Shah Rajeev M.	Director, 10% Owner	A Award deriv	2018-06-28	2018-07-02	15,000	—	$0	15,000	SEC↗
Bisgaard Peter	Director	A Award deriv	2018-06-28	2018-07-02	15,000	—	$0	15,000	SEC↗
PEARSON TIMOTHY R	Director	A Award deriv	2018-06-28	2018-07-02	15,000	—	$0	15,000	SEC↗
Heft Robert	Director	A Award deriv	2018-06-28	2018-07-02	15,000	—	$0	15,000	SEC↗
Mathers Edward T	Director	A Award deriv	2018-06-28	2018-07-02	15,000	—	$0	15,000	SEC↗
Kolchinsky Peter	Director, 10% Owner	A Award deriv	2018-06-28	2018-07-02	15,000	—	$0	15,000	SEC↗
King John C	Chief Commercial Officer	A Award deriv	2018-05-01	2018-05-02	45,987	—	$0	45,987	SEC↗
King John C	Chief Commercial Officer	A Award deriv	2018-05-01	2018-05-02	190,000	—	$0	190,000	SEC↗
NEA 13 GP, Ltd	10% Owner	P Buy	2018-02-16	2018-02-21	2,000,000	$6.00	$12.00M	5,490,073	SEC↗
Kolchinsky Peter	10% Owner	P Buy	2018-02-14	2018-02-16	2,500,000	$6.00	$15.00M	3,851,808	SEC↗
Shah Rajeev M.	Director, 10% Owner	P Buy	2018-02-14	2018-02-16	2,500,000	$6.00	$15.00M	3,851,808	SEC↗
Treco Douglas A	President and CEO	A Award deriv	2018-02-01	2018-02-05	125,000	—	$0	125,000	SEC↗
Treco Douglas A	President and CEO	A Award deriv	2018-02-01	2018-02-05	62,500	—	$0	62,500	SEC↗
Lubner David Charles	Executive V.P. & CFO	A Award deriv	2018-02-01	2018-02-05	62,500	—	$0	62,500	SEC↗
Lubner David Charles	Executive V.P. & CFO	A Award deriv	2018-02-01	2018-02-05	31,250	—	$0	31,250	SEC↗
Read Simon	Chief Scientific Officer	A Award deriv	2018-02-01	2018-02-05	27,500	—	$0	27,500	SEC↗
Read Simon	Chief Scientific Officer	A Award deriv	2018-02-01	2018-02-05	55,000	—	$0	55,000	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	A Award deriv	2018-02-01	2018-02-05	62,500	—	$0	62,500	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	A Award deriv	2018-02-01	2018-02-05	31,250	—	$0	31,250	SEC↗
Bisgaard Peter	Director	A Award deriv	2017-10-26	2017-10-30	15,000	—	$0	15,000	SEC↗
Kolchinsky Peter	Director	A Award deriv	2017-06-20	2017-06-22	15,000	—	$0	15,000	SEC↗
PEARSON TIMOTHY R	Director	A Award deriv	2017-06-20	2017-06-22	15,000	—	$0	15,000	SEC↗
Shah Rajeev M.	Director	A Award deriv	2017-06-20	2017-06-22	15,000	—	$0	15,000	SEC↗
Heft Robert	Director	A Award deriv	2017-06-20	2017-06-22	15,000	—	$0	15,000	SEC↗
Mathers Edward T	Director	A Award deriv	2017-06-20	2017-06-22	15,000	—	$0	15,000	SEC↗
Lettmann Jason	Director, 10% Owner	A Award deriv	2017-06-20	2017-06-22	15,000	—	$0	15,000	SEC↗
NOVARTIS AG	10% Owner	S Sale	2017-06-19	2017-06-20	3,220	$22.02	$70.9K	2,251,457	SEC↗
NOVARTIS AG	10% Owner	S Sale	2017-06-16	2017-06-20	53,200	$21.24	$1.13M	2,254,677	SEC↗
NOVARTIS AG	10% Owner	S Sale	2017-06-08	2017-06-12	700	$22.00	$15.4K	2,307,877	SEC↗
NOVARTIS AG	10% Owner	S Sale	2017-06-07	2017-06-08	4,840	$22.11	$107.0K	2,308,577	SEC↗
NOVARTIS AG	10% Owner	S Sale	2017-06-06	2017-06-08	7,274	$22.98	$167.2K	2,313,417	SEC↗
Novartis Bioventures Ltd	10% Owner	S Sale	2017-06-05	2017-06-06	4,780	$23.11	$110.5K	2,320,691	SEC↗
Novartis Bioventures Ltd	10% Owner	S Sale	2017-06-02	2017-06-06	14,867	$23.47	$348.9K	2,325,471	SEC↗
NOVARTIS AG	10% Owner	S Sale	2017-06-01	2017-06-02	10,722	$23.89	$256.1K	2,340,338	SEC↗
NOVARTIS AG	10% Owner	S Sale	2017-05-31	2017-06-02	35,539	$23.94	$850.8K	2,351,060	SEC↗
NOVARTIS AG	10% Owner	S Sale	2017-05-26	2017-05-30	5,300	$25.14	$133.2K	2,386,599	SEC↗
NOVARTIS AG	10% Owner	S Sale	2017-05-25	2017-05-30	53	$25.00	$1.3K	2,391,899	SEC↗
NOVARTIS AG	10% Owner	S Sale	2017-05-24	2017-05-25	17,451	$25.01	$436.4K	2,391,952	SEC↗
Novartis Bioventures Ltd	10% Owner	S Sale	2017-05-18	2017-05-22	9,019	$25.50	$230.0K	2,409,403	SEC↗
NOVARTIS AG	10% Owner	S Sale	2017-05-17	2017-05-18	22,534	$25.51	$574.8K	2,418,422	SEC↗
NOVARTIS AG	10% Owner	S Sale	2017-05-16	2017-05-18	20,081	$26.33	$528.7K	2,440,956	SEC↗
NOVARTIS AG	10% Owner	S Sale	2017-03-01	2017-05-02	7,778	$20.91	$162.6K	2,461,037	SEC↗
NOVARTIS AG	10% Owner	S Sale	2017-02-28	2017-05-02	7,847	$20.86	$163.7K	2,468,815	SEC↗
NOVARTIS AG	10% Owner	S Sale	2017-02-27	2017-05-02	57,844	$20.96	$1.21M	2,476,662	SEC↗
NOVARTIS AG	10% Owner	S Sale	2017-02-24	2017-05-02	5,398	$20.93	$113.0K	2,534,506	SEC↗
NOVARTIS AG	10% Owner	S Sale	2017-02-23	2017-05-02	4,999	$21.04	$105.2K	2,539,904	SEC↗
NOVARTIS AG	10% Owner	S Sale	2017-02-22	2017-05-02	749	$21.86	$16.4K	2,544,903	SEC↗
Farzaneh-Far Ramin	Chief Medical Officer	A Award deriv	2017-02-01	2017-02-03	90,000	—	$0	90,000	SEC↗
Lubner David Charles	Executive V.P. & CFO	A Award deriv	2017-02-01	2017-02-03	112,500	—	$0	112,500	SEC↗
Read Simon	Chief Scientific Officer	A Award deriv	2017-02-01	2017-02-03	67,500	—	$0	67,500	SEC↗
Treco Douglas A	President & CEO	A Award deriv	2017-02-01	2017-02-03	225,000	—	$0	225,000	SEC↗
NEA 13 GP, Ltd	10% Owner	C Conversion deriv	2016-10-31	2016-10-31	12,447,605	—	$0	0	SEC↗
NEA 13 GP, Ltd	10% Owner	C Conversion deriv	2016-10-31	2016-10-31	4,689,657	—	$0	0	SEC↗
NEA 13 GP, Ltd	10% Owner	C Conversion deriv	2016-10-31	2016-10-31	4,362,472	—	$0	0	SEC↗
NEA 13 GP, Ltd	10% Owner	X Exercise deriv	2016-10-31	2016-10-31	80,658	—	$0	0	SEC↗
BARRETT M JAMES	10% Owner	C Conversion deriv	2016-10-31	2016-10-31	4,689,657	—	$0	0	SEC↗
BARRETT M JAMES	10% Owner	C Conversion deriv	2016-10-31	2016-10-31	12,447,605	—	$0	0	SEC↗
BARRETT M JAMES	10% Owner	X Exercise deriv	2016-10-31	2016-10-31	80,658	—	$0	0	SEC↗
BARRETT M JAMES	10% Owner	C Conversion deriv	2016-10-31	2016-10-31	4,362,472	—	$0	0	SEC↗
BARRIS PETER J	10% Owner	C Conversion deriv	2016-10-31	2016-10-31	4,689,657	—	$0	0	SEC↗
BARRIS PETER J	10% Owner	C Conversion deriv	2016-10-31	2016-10-31	12,447,605	—	$0	0	SEC↗
BARRIS PETER J	10% Owner	C Conversion deriv	2016-10-31	2016-10-31	4,362,472	—	$0	0	SEC↗
BARRIS PETER J	10% Owner	X Exercise deriv	2016-10-31	2016-10-31	80,658	—	$0	0	SEC↗
BASKETT FOREST	10% Owner	C Conversion deriv	2016-10-31	2016-10-31	12,447,605	—	$0	0	SEC↗
BASKETT FOREST	10% Owner	X Exercise deriv	2016-10-31	2016-10-31	80,658	—	$0	0	SEC↗
BASKETT FOREST	10% Owner	C Conversion deriv	2016-10-31	2016-10-31	4,689,657	—	$0	0	SEC↗
BASKETT FOREST	10% Owner	C Conversion deriv	2016-10-31	2016-10-31	4,362,472	—	$0	0	SEC↗
KERINS PATRICK J	10% Owner	X Exercise deriv	2016-10-31	2016-10-31	80,658	—	$0	0	SEC↗
KERINS PATRICK J	10% Owner	C Conversion deriv	2016-10-31	2016-10-31	12,447,605	—	$0	0	SEC↗
KERINS PATRICK J	10% Owner	C Conversion deriv	2016-10-31	2016-10-31	4,689,657	—	$0	0	SEC↗
KERINS PATRICK J	10% Owner	C Conversion deriv	2016-10-31	2016-10-31	4,362,472	—	$0	0	SEC↗
NOVARTIS AG	10% Owner	C Conversion deriv	2016-10-31	2016-10-31	3,402,729	—	$0	0	SEC↗
NOVARTIS AG	10% Owner	X Exercise deriv	2016-10-31	2016-10-31	62,914	—	$0	0	SEC↗
NOVARTIS AG	10% Owner	C Conversion deriv	2016-10-31	2016-10-31	9,728,589	—	$0	0	SEC↗
NOVARTIS AG	10% Owner	C Conversion deriv	2016-10-31	2016-10-31	3,657,932	—	$0	0	SEC↗
KOLLURI KRISHNA KITTU	10% Owner	C Conversion deriv	2016-10-31	2016-10-31	4,362,472	—	$0	0	SEC↗
KOLLURI KRISHNA KITTU	10% Owner	C Conversion deriv	2016-10-31	2016-10-31	4,689,657	—	$0	0	SEC↗
KOLLURI KRISHNA KITTU	10% Owner	X Exercise deriv	2016-10-31	2016-10-31	80,658	—	$0	0	SEC↗
KOLLURI KRISHNA KITTU	10% Owner	C Conversion deriv	2016-10-31	2016-10-31	12,447,605	—	$0	0	SEC↗
MOTT DAVID M	10% Owner	X Exercise deriv	2016-10-31	2016-10-31	80,658	—	$0	0	SEC↗
MOTT DAVID M	10% Owner	C Conversion deriv	2016-10-31	2016-10-31	4,689,657	—	$0	0	SEC↗
MOTT DAVID M	10% Owner	C Conversion deriv	2016-10-31	2016-10-31	12,447,605	—	$0	0	SEC↗
MOTT DAVID M	10% Owner	C Conversion deriv	2016-10-31	2016-10-31	4,362,472	—	$0	0	SEC↗
Lettmann Jason	Director	C Conversion deriv	2016-10-31	2016-10-31	3,798,914	—	$0	0	SEC↗
Lettmann Jason	Director	C Conversion deriv	2016-10-31	2016-10-31	481,503	—	$0	0	SEC↗
Lettmann Jason	Director	C Conversion deriv	2016-10-31	2016-10-31	3,664,071	—	$0	0	SEC↗
Lettmann Jason	Director	C Conversion deriv	2016-10-31	2016-10-31	3,408,439	—	$0	0	SEC↗
Lettmann Jason	Director	C Conversion deriv	2016-10-31	2016-10-31	3,533,875	—	$0	0	SEC↗
Lettmann Jason	Director	C Conversion deriv	2016-10-31	2016-10-31	9,744,916	—	$0	0	SEC↗
Lettmann Jason	Director	X Exercise deriv	2016-10-31	2016-10-31	63,019	—	$0	0	SEC↗
Lettmann Jason	Director	C Conversion deriv	2016-10-31	2016-10-31	517,617	—	$0	0	SEC↗
SANDELL SCOTT D	10% Owner	X Exercise deriv	2016-10-31	2016-10-31	80,658	—	$0	0	SEC↗
SANDELL SCOTT D	10% Owner	C Conversion deriv	2016-10-31	2016-10-31	12,447,605	—	$0	0	SEC↗
SANDELL SCOTT D	10% Owner	C Conversion deriv	2016-10-31	2016-10-31	4,362,472	—	$0	0	SEC↗
SANDELL SCOTT D	10% Owner	C Conversion deriv	2016-10-31	2016-10-31	4,689,657	—	$0	0	SEC↗
Viswanathan Ravi	10% Owner	C Conversion deriv	2016-10-31	2016-10-31	4,362,472	—	$0	0	SEC↗
Viswanathan Ravi	10% Owner	X Exercise deriv	2016-10-31	2016-10-31	80,658	—	$0	0	SEC↗
Viswanathan Ravi	10% Owner	C Conversion deriv	2016-10-31	2016-10-31	12,447,605	—	$0	0	SEC↗
Viswanathan Ravi	10% Owner	C Conversion deriv	2016-10-31	2016-10-31	4,689,657	—	$0	0	SEC↗
MORGENTHALER VENTURE PARTNERS	10% Owner	C Conversion deriv	2016-10-31	2016-10-31	3,664,071	—	$0	0	SEC↗
MORGENTHALER VENTURE PARTNERS	10% Owner	C Conversion deriv	2016-10-31	2016-10-31	9,744,916	—	$0	0	SEC↗
MORGENTHALER VENTURE PARTNERS	10% Owner	C Conversion deriv	2016-10-31	2016-10-31	3,408,439	—	$0	0	SEC↗
MORGENTHALER VENTURE PARTNERS	10% Owner	X Exercise deriv	2016-10-31	2016-10-31	63,019	—	$0	0	SEC↗
Weller Harry R	10% Owner	C Conversion deriv	2016-10-31	2016-10-31	12,447,605	—	$0	0	SEC↗
Weller Harry R	10% Owner	C Conversion deriv	2016-10-31	2016-10-31	4,362,472	—	$0	0	SEC↗
Weller Harry R	10% Owner	C Conversion deriv	2016-10-31	2016-10-31	4,689,657	—	$0	0	SEC↗
Weller Harry R	10% Owner	X Exercise deriv	2016-10-31	2016-10-31	80,658	—	$0	0	SEC↗
Lubner David Charles	EVP & CFO	A Award deriv	2016-10-31	2016-10-31	29,285	—	$0	29,285	SEC↗
RA Capital Healthcare Fund LP	10% Owner	C Conversion deriv	2016-10-31	2016-10-31	4,316,531	—	$0	0	SEC↗
RA Capital Healthcare Fund LP	10% Owner	C Conversion deriv	2016-10-31	2016-10-31	4,015,378	—	$0	0	SEC↗
Shah Rajeev M.	Director	C Conversion deriv	2016-10-31	2016-10-31	4,316,531	—	$0	0	SEC↗
Shah Rajeev M.	Director	C Conversion deriv	2016-10-31	2016-10-31	4,015,378	—	$0	0	SEC↗
Novo A/S	10% Owner	C Conversion deriv	2016-10-31	2016-11-02	860,438	—	$0	0	SEC↗
Novo A/S	10% Owner	C Conversion deriv	2016-10-31	2016-11-02	924,970	—	$0	0	SEC↗
NEA 13 GP, Ltd	10% Owner	P Buy	2016-10-31	2016-10-31	338,462	$13.00	$4.40M	3,490,073	SEC↗
NEA 13 GP, Ltd	10% Owner	C Conversion	2016-10-31	2016-10-31	623,210	—	$0	3,151,611	SEC↗
NEA 13 GP, Ltd	10% Owner	C Conversion	2016-10-31	2016-10-31	669,951	—	$0	2,528,401	SEC↗
NEA 13 GP, Ltd	10% Owner	C Conversion	2016-10-31	2016-10-31	1,778,227	—	$0	1,858,450	SEC↗
NEA 13 GP, Ltd	10% Owner	S Sale	2016-10-31	2016-10-31	435	$13.00	$5.7K	80,223	SEC↗
NEA 13 GP, Ltd	10% Owner	X Exercise	2016-10-31	2016-10-31	80,658	$0.07	$5.6K	80,658	SEC↗
BARRETT M JAMES	10% Owner	P Buy	2016-10-31	2016-10-31	338,462	$13.00	$4.40M	3,490,073	SEC↗
BARRETT M JAMES	10% Owner	C Conversion	2016-10-31	2016-10-31	623,210	—	$0	3,151,611	SEC↗